MedPath

Discontinuation of Antibiotic Susceptibility Testing on Enterococcus Faecalis Positive Urine Cultures in Hospitalized Patients: an Impact on Antibiotic Prescriptions? (FaecaCible)

Completed
Conditions
Antibiotic Susceptibility Reporting
Interventions
Other: Stop performing an antibiotic susceptibility test
Registration Number
NCT05743192
Lead Sponsor
Central Hospital, Nancy, France
Brief Summary

The objective of the study is to evaluate the impact of not reporting antibiotic susceptibility tests on antibiotic consumption for Enterococcus faecalis positive urine cultures in adult hospitalized patients. The secondary objectives are to evaluate the impact of this intervention on antibiotic prescription rates as well as on antibiotic consumption according to: patient gender, type of antibiotic therapy (probabilistic/documented) and diagnosis (urinary tract infection or colonization). It is hypothesized that antibiotic consumption is lower after the application of the absence of antibiotic susceptibility reporting compared to before.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
217
Inclusion Criteria
  • Person having received complete information on the organization of the research and not having objected to the exploitation of these data
  • Adult patients (More than 18);
  • Having performed a urine culture at the Nancy University Hospital, taken from the 2nd urine stream, by urinary catheter or via a suprapubic catheter and whose culture is positive for monomicrobial E. faecalis with a bacteriuria threshold greater than or equal to 10^3 CFU/field;
  • Hospitalized at the Nancy University Hospital at least 72 hours after validation of the antibiotic susceptibility test in the pre-intervention period and at least 72 hours after validation of the culture in the post-intervention period.
Exclusion Criteria
  • Inpatients in hematology, critical care/intensive care, consultation and day hospital units;
  • Urine cultures performed in ambulatory units ;
  • Urine culture performed in the critical care/intensive care/hematology units;
  • Patients discharged from hospital/deceased/transferred to intensive care within 72 hours of the validation of the antibiotic susceptibility test or the validation of the urine culture;
  • Patients with associated E. faecalis bacteremia;
  • Urine culture without an antibiotic susceptibility test for the pre-intervention period;
  • Urine culture with a monomicrobial history of less than 1 week;
  • Culture of urine from pyelic punctures or nephrostomy tubes - conservation of those from second streams, urinary catheters and suprapubic catheters).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
After groupStop performing an antibiotic susceptibility testGroup of patients with a positive urine culture for Enterococcus faecalis after the procedure consisting of systematically performing an antibiotic susceptibility test.
Primary Outcome Measures
NameTimeMethod
Proportion of positive urine culture for which antibiotic therapy was prescribed (%)Between 24 hours before the urine culture is collected and 72 hours following the validation of the antibiotic susceptibility test/the urine culture by the biologist
Secondary Outcome Measures
NameTimeMethod
Prescription rate of each antibiotic class/molecule (%)Between 24 hours before the urine culture is collected and 72 hours following the validation of the antibiotic susceptibility test/the urine culture by the biologist
Prescription rate of each antibiotic class/molecule (%) by patient genderBetween 24 hours before the urine culture is collected and 72 hours following the validation of the antibiotic susceptibility test/the urine culture by the biologist
Proportion of urine cultures for which antibiotic therapy was prescribed (%) by diagnosisBetween 24 hours before the urine culture is collected and 72 hours following the validation of the antibiotic susceptibility test/the urine culture by the biologist

Diagnosis = UTI or UCC

Prescription rate of each antibiotic class/molecule (%) by type of antibiotic therapy.Between 24 hours before the urine culture is collected and 72 hours following the validation of the antibiotic susceptibility test/the urine culture by the biologist
Proportion of urine cultures for which antibiotic therapy was prescribed (%) by sex of patientBetween 24 hours before the urine culture is collected and 72 hours following the validation of the antibiotic susceptibility test/the urine culture by the biologist
Proportion of urine cultures for which antibiotic therapy was prescribed (%) by type of antibiotic therapy.Between 24 hours before the urine culture is collected and 72 hours following the validation of the antibiotic susceptibility test/the urine culture by the biologist

Type of antibiotic therapy = probabilistic or documented

Prescription rate of each antibiotic class/molecule (%) by diagnosisBetween 24 hours before the urine culture is collected and 72 hours following the validation of the antibiotic susceptibility test/the urine culture by the biologist

Diagnosis = UTI or UCC

Trial Locations

Locations (1)

Nancy University Hospital

🇫🇷

Vandœuvre-lès-Nancy, France

© Copyright 2025. All Rights Reserved by MedPath